Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

, VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

09:08
08/14/18
08/14
09:08
08/14/18
09:08
Conference/Events
Wedbush to hold a conference »

2018 Wedbush PacGrow…

KPTI

Karyopharm

$18.03

-0.04 (-0.22%)

VYGR

Voyager Therapeutics

$17.72

-0.44 (-2.42%)

VRNA

Verona Pharma

$13.40

-0.47 (-3.39%)

AVRO

AvroBio

$40.60

0.61 (1.53%)

ASND

Ascendis Pharma

$68.50

0.82 (1.21%)

OBSV

ObsEva

$14.00

-0.96 (-6.42%)

OMER

Omeros

$19.18

1.41 (7.93%)

NVCR

Novocure

$36.95

1 (2.78%)

XNCR

Xencor

$40.69

0.38 (0.94%)

PRTK

Paratek Pharmaceuticals

$9.65

-0.4 (-3.98%)

MGTA

Magenta Therapeutics

$12.90

-0.16 (-1.23%)

CRVS

Corvus Pharmaceuticals

$9.43

0.12 (1.29%)

AKAO

Achaogen

$5.82

-0.35 (-5.67%)

ALBO

Albireo Pharma

$31.60

0.42 (1.35%)

EIGR

Eiger BioPharmaceuticals

$9.68

0.025 (0.26%)

STML

Stemline

$15.15

0.15 (1.00%)

SRRA

Sierra Oncology

$2.06

(0.00%)

ABUS

Arbutus Biopharma

$9.65

0.15 (1.58%)

MRSN

Mersana Therapeutics

$12.71

-0.205 (-1.59%)

SRRK

Scholar Rock

$13.29

-1.11 (-7.71%)

ARGX

Argenx

$87.31

-2.79 (-3.10%)

ALNA

Allena Pharmaceuticals

$10.87

0.13 (1.21%)

KURA

Kura Oncology

$19.95

0.95 (5.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 16

    Aug

  • 19

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 05

    Sep

  • 21

    Feb

ALNY

Alnylam

$90.92

-6.48 (-6.65%)

08:11
08/14/18
08/14
08:11
08/14/18
08:11
Conference/Events
Alnylam management to hold 8th annual RNAi Roundtable »

Management holds its 8th…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

Monday
ALNY

Alnylam

$89.65

-7.75 (-7.96%)

, RUBY

Rubius Therapeutics

$23.55

-0.32 (-1.34%)

11:24
08/13/18
08/13
11:24
08/13/18
11:24
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

ALNY

Alnylam

$89.65

-7.75 (-7.96%)

RUBY

Rubius Therapeutics

$23.55

-0.32 (-1.34%)

AMZN

Amazon.com

$1,916.60

30.61 (1.62%)

NFLX

Netflix

$343.81

-2.07 (-0.60%)

DISH

Dish

$34.74

-0.43 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 16

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

  • 13

    Sep

RAD

Rite Aid

$1.39

-0.085 (-5.76%)

, AKAM

Akamai

$73.37

-1.29 (-1.73%)

10:08
08/13/18
08/13
10:08
08/13/18
10:08
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

RAD

Rite Aid

$1.39

-0.085 (-5.76%)

AKAM

Akamai

$73.37

-1.29 (-1.73%)

ALNY

Alnylam

$90.03

-7.37 (-7.57%)

GT

Goodyear Tire

$23.84

-0.44 (-1.81%)

DISH

Dish

$34.57

-0.6 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 04

    Sep

  • 11

    Sep

  • 12

    Sep

ABUS

Arbutus Biopharma

$9.50

-0.3 (-3.06%)

, ALNY

Alnylam

$97.40

3.13 (3.32%)

08:37
08/13/18
08/13
08:37
08/13/18
08:37
Hot Stocks
Arbutus Biopharma, Alnylam announce NDA approval by the FDA »

Arbutus Biopharma (ABUS)…

ABUS

Arbutus Biopharma

$9.50

-0.3 (-3.06%)

ALNY

Alnylam

$97.40

3.13 (3.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

ALNY

Alnylam

$97.40

3.13 (3.32%)

07:42
08/13/18
08/13
07:42
08/13/18
07:42
Recommendations
Alnylam analyst commentary at Morgan Stanley »

Alnylam price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

ALNY

Alnylam

$97.40

3.13 (3.32%)

, PFE

Pfizer

$40.93

-0.08 (-0.20%)

07:31
08/13/18
08/13
07:31
08/13/18
07:31
Recommendations
Alnylam, Pfizer analyst commentary at Nomura Instinet »

Alnylam price target…

ALNY

Alnylam

$97.40

3.13 (3.32%)

PFE

Pfizer

$40.93

-0.08 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 19

    Aug

  • 22

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

ALNY

Alnylam

$97.40

3.13 (3.32%)

06:54
08/13/18
08/13
06:54
08/13/18
06:54
Recommendations
Alnylam analyst commentary at Stifel »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

ALNY

Alnylam

$97.40

3.13 (3.32%)

, PFE

Pfizer

$40.93

-0.08 (-0.20%)

05:34
08/13/18
08/13
05:34
08/13/18
05:34
Downgrade
Alnylam, Pfizer rating change at Goldman Sachs »

Alnylam downgraded to Buy…

ALNY

Alnylam

$97.40

3.13 (3.32%)

PFE

Pfizer

$40.93

-0.08 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 19

    Aug

  • 22

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

ALNY

Alnylam

$97.40

3.13 (3.32%)

05:12
08/13/18
08/13
05:12
08/13/18
05:12
Recommendations
Alnylam analyst commentary at Piper Jaffray »

Alnylam should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 25

    Aug

  • 30

    Aug

  • 31

    Aug

  • 04

    Sep

  • 11

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.